Just one quarter in without its clinical development business, Labcorp is seeing its new laboratory strategy pay off. The company saw its base business (operations outside of Covid-19) increase 14%, helping revenue jump 6.6% year-over-year. Here's how Labcorp's Q3 went and what it means for the laboratory and diagnostics company.
